Título original
[Patients With Limited-Stage Small-Cell Lung Cancer Treated with Concurrent Twice-Daily Chest Radiotherapy and Etoposide/Cisplatin Followed by Cyclophosphamide, Doxorubicin, and Vincristine]

Título en castellano
Un estudio en pacientes con cancer pulmonar de células pequeñas con estadio limitado en tratamiento concurrente con radioterapia toracica dos veces al dia y etoposido/cisplatino seguidos de ciclofosfamida, doxorrubicina y vincristina.

Autores
Johnson BE, Bridges JD, Sobczeck M, y colaboradores

Institución
National Cancer Institute-Navy Medical Oncology, Radiation Oncology, and Surgery Branches, Biostatistics and Data Management Section, National Cancer Institute; Medicine, Surgery, and Radiology Departments, National Naval Medical Center Uniformed Services, University of the Health Sciences, Bethesda, Maryland, EE.UU.